Ramat Gan, Israel

Gal Markel

This inventor holds 1 USPTO granted patent. Top assignee: 4C Biomed Limited. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gal Markel. Retrieved from https://idiyas.com/inventor/gal-markel-yv2d2doa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gal Markel: Innovator in Antibody Research

Introduction

Gal Markel is a prominent inventor based in Ramat Gan, Israel. He has made significant contributions to the field of biomedical research, particularly in the development of innovative antibody therapies. His work is characterized by a commitment to advancing medical science and improving patient outcomes.

Latest Patents

Gal Markel holds a patent for "ANTI-HVEM ANTIBODIES AND USE THEREOF." This patent represents a crucial advancement in the understanding and application of antibodies in therapeutic settings. With 1 patent to his name, Markel's contributions are noteworthy in the realm of antibody research.

Career Highlights

Markel is currently associated with 4C Biomed Limited, a company dedicated to pioneering advancements in biomedical technologies. His role at the company allows him to leverage his expertise in antibody development to create innovative solutions for healthcare challenges.

Collaborations

Throughout his career, Gal Markel has collaborated with notable colleagues, including Eyal Greenberg and Gilli Galore-Haskel. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Gal Markel's work in antibody research exemplifies the spirit of innovation in the biomedical field. His contributions, particularly through his patent, highlight the importance of continued research and collaboration in advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…